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Abstract
Background: Prevalence estimates of chronic medical conditions and their multiples (multimorbidity) in the general
population are scarce and often rather speculative in Switzerland. Using complementary data sources, we assessed
estimates validity of population-based prevalence rates of four common chronic medical conditions with high impact
on cardiovascular health (diabetes mellitus, hypertension, dyslipidemia, obesity).
Methods: We restricted our analyses to patients 15-94 years old living in the German speaking part of Switzerland. Data
sources were: Swiss Health Survey (SHS, 2007, n = 13,580); Family Medicine ICPC Research using Electronic Medical
Record Database (FIRE, 2010-12, n = 99,441); and hospital discharge statistics (MEDSTAT, 2009-10, n = 883,936). We defined
chronic medical conditions based on use of drugs, diagnoses, and measurements.
Results: After a careful harmonization of the definitions, a high degree of concordance, especially regarding the age- and
gender-specific distribution patterns, was found for diabetes mellitus (defined as drug use or diagnosis in SHS, drug use
or diagnosis or blood glucose measurement in FIRE, and ICD-10 codes E10-14 as secondary diagnosis in MEDSTAT) and
for hypertension (defined as drug use alone in SHS and FIRE, and ICD-10 codes I10-15 or I67.4 as secondary diagnosis in
MEDSTAT). A lesser degree of concordance was found for dyslipidemia (defined as drug use alone in SHS and FIRE, and
ICD-10 code E78 in MEDSTAT), and for obesity (defined as BMI ≥ 30 kg/m2 derived from self-reported height and weight
in SHS, from measured height and weight or diagnosis of obesity in FIRE, and ICD-10 code E66 as secondary diagnosis in
MEDSTAT). MEDSTAT performed well for clearly defined diagnoses (diabetes, hypertension), but underrepresented
systematically more symptomatic conditions (dyslipidemia, obesity).
Conclusion: Complementary data sources can provide different prevalence estimates of chronic medical conditions in
the general population. However, common age and sex patterns indicate that a careful harmonization of the definition
of each chronic medical condition permits a high degree of concordance.
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Background
Due to demographic ageing and advances in medical
care the prevalence of chronic medical conditions and
multimorbidity (defined as more than one chronic
medical condition in one individual [1]) is increasing
worldwide. Estimates from the United States suggest
that by 2020, nearly 50% of the population will have at
least one chronic medical condition, with most suffering
from multimorbidity [2].
However, measuring prevalence rates of chronic medical
conditions poses challenges, because of varying case
definitions (medical nosology, inclusion of symptoms,
laboratory values, and prescribed medication), differ-
ent methods of case identification (self-report, clinical
exam, registry), and diverse sampling strategies (general
population, general practice population, population in
specific medical care settings). Population surveys
using solely information on self-reported diagnoses are
additionally influenced by informational and recall biases.
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Therefore, prevalence estimates vary widely across
different studies.
Despite its significance for public health, population
based estimates of prevalence rates of chronic medical
conditions and multimorbidity are scarce in Switzerland.
A recently published study explored the prevalence of
chronic medical conditions and multimorbidity in primary
care in the German speaking part of Switzerland and
found that multimorbidity was more common than the
most prevalent single chronic medical condition, hyper-
tension (15% vs. 9%) [3]. However, a relative small number
of participating primary care providers, varying coding
practices, and a potential selection bias (individuals con-
sulting a doctor might be sicker than the average popula-
tion), did not allow an uncritical generalization of the
results to the entire population.
“Cross-validation” of different health statistics has been
shown to be a promising way to obtain valid estimates of
prevalence rates of diabetes mellitus in Switzerland [4].
Even when absolute numbers diverge, similarities regard-
ing age- and gender-specific distribution patterns increase
the validity of the estimates. However, simply contrasting
data from primary care with survey data will not suffice,
as has been shown for prevalence estimates of multimor-
bidity in Canadian settings [5].
Therefore, we explored similarities and differences be-
tween Swiss health statistics (Swiss Health Survey [SHS],
primary care data [FIRE], and hospital discharge statistics
[MEDSTAT]), regarding four common chronic conditions
with high impact on cardiovascular health: hypertension,
diabetes mellitus, dyslipidemia, and obesity. We hypothe-
sized that with a careful definition of each chronic condi-
tion and each data source we will be able to harmonize
the estimates despite different sampling techniques
(self-report, physician report, drug prescription, meas-
urement). We also expected to find hints concerning
over- or under-reporting of specific chronic medical
conditions in specific data sources.
Methods
Data sources
Swiss health survey 2007 (SHS)
The Swiss Health Survey (SHS) is conducted since
1992 every five years, targets the general population of
Switzerland ≥15 years, and provides nationally repre-
sentative information on health-related behavior and
attitudes, as well as frequency and type of healthcare
utilization. Eligible subjects are chosen by stratified ran-
dom sampling (based on telephone registry) of private
households with landline telephone. Within each con-
tacted household, one member is randomly selected (ran-
dom-random-procedure) for computer assisted telephone
interview. Details regarding the sampling procedure are
provided elsewhere (http://www.bfs.admin.ch/bfs/portal/
de/index/infothek/erhebungen__quellen/blank/blank/ess/04.
html). In 2007, 17,931 individuals participated in the inter-
view (participation rate 66%).
Primary care data 2010-2012 (FIRE)
We obtained primary care based data from the Swiss
Family Medicine International Classification of Primary
Care (ICPC) Research using Electronic Medical Record
project (FIRE), which was initiated 2009 by the SGAM
(Association of Swiss General Practitioners) and coordi-
nated by the Institute of General Practice at the University
of Zurich, Zurich, Switzerland [6]. Primary care physicians
in the German speaking part of Switzerland (who used
electronic patient records) provided voluntarily standard-
ized, anonymized data on all patient-physician encounters
(patient’s demographics, vital signs, diagnostic codes using
the second version of the International Classification of
Primary Care [ICPC-2], laboratory values, and medication
using the Anatomical Therapeutic Chemical Classification
System [ATC]). Between May 2010 and April 2012, there
were 556,353 consultations in 113,318 patients. For a valid
comparison of MEDSTAT (ICD-10 classification system)
and FIRE (ICPC-2 classification system), we used an
IT-tool programmed by the Academic Medical Center,
University Amsterdam, that translates ICPC-2 to ICD-10
codes [7].
Hospital discharge statistics 2009-2010 (MEDSTAT)
In Switzerland, hospital discharges are routinely registered
since 1998. The data include gender, age, and region of
residence, other administrative variables, and one princi-
pal diagnosis and up to 49 additional (“secondary”) diag-
noses encoded according to the International Statistical
Classification of Diseases (ICD-10). Hospitalizations con-
cerning the same individual can be identified (http://www.bfs.
admin.ch/bfs/portal/de/index/infothek/erhebungen__quellen/
blank/blank/mkh/01.html). In 2009 and 2010, MEDSTAT
constituted of 2.673 million hospital discharges in 1.715
million patients.
Data protection
SHS and MEDSTATare administered by the Swiss Federal
Statistics Office as a part of its legal mission. The use of
fully anonymized individual data from these sources is
subject to specific data contracts with the Institute of
Social and Preventive Medicine. FIRE data are fully anon-
ymized and stored on a central server. Only two of the
authors (SD, VK) had access to the data. According to the
current Swiss law on human research (Humanforschungs-
gesetz, HFG) retrospective analyses of anonymized med-
ical routine data do not requires approval by the regional
ethics committee http://www.bag.admin.ch/themen/medi-
zin/00701/00702/07558/.
Zellweger et al. BMC Public Health 2014, 14:1157 Page 2 of 12
http://www.biomedcentral.com/1471-2458/14/1157
Definitions of chronic conditions
Health survey 2007 (SHS)
We used the following items of the survey to define the
chronic conditions (Table 1):
Diabetes mellitus: Did you take any medication for
diabetes or used insulin in the last seven days? Were you
ever told by a physician that you have diabetes? Hyperten-
sion: Did you take any medication for high blood pressure
in the last seven days? Were you ever told by a physician
or another health professional to have high blood pres-
sure? Dyslipidemia: Did you take any medication for high
cholesterol (lipids) in the last seven days? Were you ever
told by your physician or another health professional to
have high blood cholesterol (lipids)? Obesity: Body mass
index (BMI) ≥30 kg/m2, derived from self-reported height
and weight.
Table 1 Case definition of diabetes mellitus, hypertension, dyslipidemia, and obesity for different data sources
Health survey 2007 (SHS) Primary care 2010-2012 (FIRE*) Hospital discharge
statistics 2009-2010
(MEDSTAT†)
Diabetes
mellitus
Drug use Drug use
Did you take medication for diabetes or injected
insulin in the last seven days?
Drugs used in diabetes (A10)
Diagnosis Diagnoses Diagnosis
Were you ever told by a physician to have
diabetes?
Diabetes insulin dependent (T89) Diabetes mellitus (E10-E14)
Diabetes non-insulin dependent (T90)
Measurement
HbA1c ≥6.5% or random plasma
glucose ≥11.1 mmol/L
Hypertension Drug use Drug use
Did you take any medication for high blood
pressure in the last seven days?
Diuretics (C03)
Peripheral vasodilators (C04)
Beta blocking agents (C07)
Calcium channel blockers (C08)
Agents acting on renin-angiotensin (C09)
Diagnosis Diagnosis Diagnosis
Were you ever told by a physician or another
health professional to have high blood pressure?
Hypertension uncomplicated (K86) Hypertension (I10-I15)
Hypertension complicated (K87)
Measurement
Systolic blood pressure ≥140 mmHg or diastolic
blood pressure ≥90 on two or more occasions
Dyslipidemia Drug use Drug use
Did you take medication for high blood cholesterol
in the last seven days?
Lipid modifying agents (C10)
Diagnosis Diagnosis Diagnosis
Were you ever told by a physician or another
health professional to have high blood cholesterol?
Lipid disorder (T93) Disorders of lipid
metabolism (E78)
Measurement
Total cholesterol >5.17 mmol/L or
triglycerides >1.69 mmol/L
Obesity Diagnosis Diagnosis
Obesity (T82) Obesity (E66)
Measurement (reported) Measurement
BMI ≥30 kg/m2 derived from self-reported height
and weight
BMI ≥30 kg/m2 derived from measured height
and weight
*International classification of primary care version 2.
†International statistical classification of diseases and related health problems, 10th revision.
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Primary care data 2010-2012 (FIRE)
We used disease-specific drugs, diagnostic codes, or la-
boratory values to define four chronic medical condi-
tions (Table 1): Diabetes mellitus: Drugs used in diabetes
mellitus (ATC codes A10); diagnostic codes for diabetes
(ICPC-2 T89 and T90); either HbA1c ≥6.5% or random
plasma glucose ≥11.1 mmol/L. Hypertension: Drugs
used for high blood pressure (ATC codes C03, C04, C07,
C08, C09); diagnostic codes for hypertension (ICPC-2
diagnoses K86 and K87); blood pressure, either systolic
blood pressure ≥140 mmHg or diastolic blood pressure
≥90 mmHg on two or more occasions. Dyslipidemia:
Drugs used as lipid modifying agents (ATC code C10);
diagnostic code (ICPC-2 diagnosis T93; cholesterol or
triglyceride (either total cholesterol ≥5.17 mmol/L or tri-
glycerides ≥1.69 mmol/L. Obesity: BMI ≥30 kg/m2 de-
rived from measured height and weight; diagnostic code
for obesity (ICPC-2 T82). Information on measured
height and weight was available for a subgroup of 26 pri-
mary care physicians who provided these measurements
in at least 20% of patient encounters.
Hospital discharge statistics 2009-2010 (MEDSTAT)
We used all disease-specific ICD-10 codes to identify
diabetes mellitus (E10-14), hypertension (I10-I15), lipid
disorder (E78), and obesity (E66). To estimate the preva-
lence rates in the general population, we restricted our
sample to patients hospitalized due to other conditions
than those explored, because we assumed that patients
with these chronic conditions as principal diagnosis
have a substantially increased risk of hospital admission and
would therefore be overrepresented compared to the general
population.
Analyses
We compared the age- and gender-specific prevalence
rates for each definition of the four chronic medical con-
ditions and for each data source. Because all FIRE primary
care physicians were located in the German speaking part
of Switzerland, we restricted all analyses to residents of
that area, thus avoiding bias due to different operating
customs as well as cultural and semantic disparities. Since
SHS provides only information on individuals 15 years
and older, we excluded individuals aged less than 15 years
at the last consultation/hospitalization in FIRE (N = 7,287)
and MEDSTAT (N= 89,135). Those aged >95 years were
also excluded because of small absolute numbers (N = 7
for SHS 2007, N = 395 for FIRE 2010-12, N = 4,296 for
MEDSTAT). Based on these selection criteria, the study
population amounted to 13,580 for SHS 2007, 99,441 for
FIRE 2010-12, and 883,936 for MEDSTAT 2009-10.
Generally, missing values, e.g. for diagnoses, could not
be discerned from negative answers and had therefore to
be handled as negation. Except for BMI in FIRE, missing
values were extremely rare (N = 184 for BMI and N = 18 for
all questions concerning diabetes in the SHS 2007, N = 7 for
age or sex in FIRE 2010-12).
Overall rates were age-standardized using the WHO
standard population “Europe”. We managed data and
conducted analyses using SPSS® Version 18 and 19 (SPSS
Inc., Chicago, IL, USA) and Stata® Version 11.2 (Stata
Corporation, College Station, TX, USA; www.stata.com).
Results
Diabetes mellitus
SHS: The standardized prevalence estimates of diabetes
mellitus defined as self-reported drug use alone, and
self-reported drug use or self-reported diagnosis of dia-
betes mellitus, were 1.7% (95% CI 1.4-1.9%) and 3.6%
(95% CI 3.2-4.0%), and 2.3% (95% CI 2.0-2.7%) and 4.6%
(95% CI 4.1-5.1%) for women and men, respectively. The
age- and gender-specific prevalence rates of diabetes mel-
litus for the two different case definitions are provided in
Figure 1a and b.
FIRE: The standardized prevalence estimates of diabetes
mellitus defined as drug prescription, drug prescription or
diagnosis, drug prescription or diagnosis or measurement
(serum glucose ≥11.1 mmol/L or HbA1c ≥6.5%), were
2.1% (95% CI 1.9-2.2%), 2.7% (95% CI 2.5-2.8%), 2.9%
(95% CI 2.7-3.0%), and 3.4% (95% CI 3.2-3.5%), 4.3%
(95% CI 4.1-4.5%), and 4.6% (95% CI 4.4-4.8%) for
women and men, respectively. The age- and gender-
specific prevalence rates of diabetes mellitus for the three
different case definitions are provided in Figure 1c and d.
MEDSTAT: The standardized prevalence rates of
diabetes mellitus defined as ICD-10 codes E10-14 as
secondary diagnoses were 3.2% (95% CI 3.2-3.2%), and
4.9% (95% CI 4.8-4.9%) for women and men, respectively.
The age- and gender-specific prevalence rates of diabetes
mellitus defined as ICD-10 codes E10-14 as secondary
diagnoses are provided in Figure 1e and f.
Hypertension
SHS: The standardized prevalence estimates of hyperten-
sion defined as self-reported drug use alone, and self-
reported drug use or self-reported diagnosis of hyperten-
sion, were 11.1% (95% CI 10.5-11.7%) and 19.2% (95% CI
18.3-20.1%), and 12.9% (95% CI 12.2-13.6%) and 23.7%
(95% CI 22.7-24.8%) for women and men, respectively.
The age- and gender-specific prevalence rates of hyperten-
sion for the different case definitions are provided in
Figure 2a and b.
FIRE: The standardized prevalence estimates of hyperten-
sion defined as drug prescription alone, drug prescription or
diagnosis of hypertension, drug prescription or diagnosis of
hypertension or measurement of high blood pressure, were
11.3% (95% CI 11.1-11.6%), 12.6% (95% CI 12.3-12.8%),
13.3% (95% CI 13.0-13.5%), and 14.2% (95% CI 14.0-14.5%),
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15.8% (95% CI 15.5-16.1%), and 16.6% (95% CI 16.3-
16.8%) for women and men, respectively. The age- and
gender-specific prevalence rates of hypertension for the
different case definitions are provided in Figure 2c and d.
MEDSTAT: The standardized prevalence estimates of
hypertension defined as ICD-10 codes I10-I15 as second-
ary diagnoses, were 10.8% (95% CI 10.7-10.8%) and 13.4%
(95% CI 13.3-13.5%) for women and men, respectively. The
age- and gender-specific prevalence rates of hypertension
defined as ICD-10 codes E10-14 as secondary diagnoses
are provided in Figure 2e and f.
Dyslipidemia
SHS: The standardized prevalence estimates of dyslipidemia
defined as self-reported drug use alone, and self-reported
drug use or self-reported diagnosis of dyslipidemia were
3.7% (95% CI 3.3-4.1%) and 12.2% (95% CI 11.5-12.9%),
and 6.3% (95% CI 5.7-6.8%) and 16.9% (95% CI 16.0-17.8%)
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Figure 1 Age- and gender-specific prevalence estimates of diabetes mellitus based on complementary data sources and various definitions.
For health survey (SHS) (a and b), we defined cases as drug use alone, and drug use or diagnosis of diabetes. For primary care data (FIRE) (c and d),
we defined cases as drug use alone, drug use or diagnosis, and drug use or diagnosis or serum glucose measurement (serum glucose ≥11.1 mmol/L
or HbA1c ≥6.5%). For hospital discharge statistics (MEDSTAT) (e and f), we defined cases as ICD-10 codes E10-14 as secondary diagnoses. Results based
on less than 30 observations are marked by an asterisk. (Data sources: Swiss Federal Statistical Office for Swiss Health Survey [SHS] and Hospital
Discharge Statistics [MEDSTAT]; Swiss Family Medicine International Classification of Primary Care Research using Electronic Medical Record project for
primary care data [FIRE]).
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for women and men, respectively. The age- and gender-
specific prevalence rates of dyslipidemia for the two differ-
ent case definitions are provided in Figure 3a and b.
FIRE: The standardized prevalence estimates of dyslipid-
emia defined as drug prescription alone, drug prescription
or diagnosis of lipid disorder, and drug prescription or
diagnosis of lipid disorder or dyslipidemia based on meas-
urement (either total cholesterol ≥5.17 mmol/L or triglycer-
ides ≥1.69 mmol/L) were 3.7% (95% CI 3.6-3.9%), 4.4%
(95% CI 4.2-4.6%), 8.5% (95% CI 8.3-8.7%), and 6.7%
(95% CI 6.5-6.9%), 7.6% (95% CI 7.4-7.8%) and 12.7% (95%
CI 12.4-12.9%) for women and men, respectively. The age-
and gender-specific prevalence rates of dyslipidemia for the
three different case definitions are provided in Figure 3c
and d.
MEDSTAT: The standardized prevalence estimates of
dyslipidemia defined as ICD-10 code E78 as secondary
diagnoses, were 2.5% (95% CI 2.4-2.5%) and 4.8% (95% CI
4.8-4.9%) for women and men, respectively. The age- and
gender-specific prevalence rates of dyslipidemia defined as
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Figure 2 Age- and gender-specific prevalence estimates of hypertension based on complementary data sources and various definitions.
For health survey (SHS) (a and b), we defined cases as drug use alone, and drug use or diagnosis of hypertension. For primary care data (FIRE)
(c and d), we defined cases as drug use alone, drug use or diagnosis of hypertension, drug use or diagnosis of hypertension or measurement
of increased blood pressure. For hospital discharge statistics (MEDSTAT) (e and f), we defined cases as ICD-10 codes I10-I15 or I67.4 as
secondary diagnoses.
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ICD-10 code E78 as secondary diagnoses are provided in
Figure 3e and f.
Obesity
SHS: The standardized prevalence estimates of obesity de-
fined as BMI ≥30 kg/m2 derived from self-reported height
and weight were 7.7% (95% CI 7.0-8.4%) and 8.4% (95% CI
7.5-9.2%) for women and men, respectively. The age- and
gender-specific prevalence rates of obesity are provided in
Figure 4a and b.
FIRE: The standardized prevalence estimates of obesity
defined as BMI ≥30 kg/m2 derived from measured
height and weight, and BMI ≥30 kg/m2 derived from
measured height and weight or diagnosis of obesity, were
7.4% (95% CI 7.0-7.8%) and 8.4% (95% CI 8.0-8.8%), and
7.6% (95% CI 7.2-7.8%) and 8.6% (95% CI 8.2-9.0%) for
women and men, respectively. The age- and gender-
specific prevalence rates of obesity for the two different
case definitions are provided in Figure 4c and d.
MEDSTAT: The standardized prevalence rates of
obesity defined as ICD-10 code E66 as secondary diag-
nosis were 4.5% (95% CI 4.5-4.6%) and 3.9% (95% CI
3.8-4.0%) for women and men, respectively. The age-
and gender-specific prevalence rates of obesity defined
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Figure 3 Age- and gender-specific prevalence estimates of dyslipidemia based on different data sources and various definitions. For
health survey (SHS) (a and b), we defined dyslipidemia as drug use alone, and drug use or diagnosis of dyslipidemia. For primary care data (FIRE)
(c and d), we defined dyslipidemia as drug use alone, drug use or diagnosis of lipid disorder, and drug use or diagnosis of lipid disorder or lipid
measurements (either total cholesterol ≥5.17 mmol/L or triglycerides ≥1.69 mmol/L). For hospital discharge statistics (MEDSTAT) (e and f), we
defined dyslipidemia as ICD-10 code E78 as secondary diagnosis. Results based on less than 30 observations are marked by an asterisk.
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as ICD-10 code E66 as secondary diagnosis are provided
in Figure 4e and f.
Comparison
Diabetes mellitus
The best harmonization for the prevalence estimates of
diabetes mellitus for the three different data sources was
achieved using the most comprehensive definitions. The
age- and gender-specific prevalence estimates of diabetes
mellitus based on SHS (defined as drug use or diagnosis
of diabetes mellitus), FIRE (defined as drug use or diag-
nosis or measurement [serum glucose ≥11.1 mmol/L or
HbA1c ≥6.5%]), and MEDSTAT (defined as ICD-10
codes E10-14 as secondary diagnoses) are contrasted in
Figure 5. These prevalence estimates were very similar
for all three data sources, rising from less than 1% in the
youngest age class (15-24 years), to more than 12% and
16% for women and men aged 75-84 years. A sharp
decline in the prevalence estimates was observed in the
oldest age class (85-94 years) of both genders.
Hypertension
The best harmonization for the prevalence estimates of
hypertension was achieved based on SHS (defined as
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f) MEDSTAT (men)
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Figure 4 Age- and gender-specific prevalence estimates of obesity based on complementary data sources and various definitions.
For health survey (SHS) (a and b), we defined obesity as BMI ≥30 kg/m2 derived from self-reported height and weight. For primary care data
(FIRE) (c and d), we defined obesity as BMI ≥30 kg/m2 derived from measured height and weight, and BMI ≥30 kg/m2 derived from measured
height and weight or diagnosis of obesity. For hospital discharge statistics (MEDSTAT) (e and f), we defined obesity as ICD-10 code E66 as
secondary diagnosis. Results based on less than 30 observations are marked by an asterisk.
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drug use alone), FIRE (defined as drug use alone), and
MEDSTAT (defined as ICD-10 codes I10-I15 as sec-
ondary diagnoses). The age- and gender-specific preva-
lence estimates (Figure 6) were very similar for the
different data sources, increasing from less than 1% in
the youngest age class (15-24 years), to more than 50%
in the oldest age class (85-94 years).
Dyslipidemia
The best harmonization for the prevalence estimates of
dyslipidemia were achieved based on SHS (defined as
drug use alone), FIRE (defined as drug use alone), and
MEDSTAT (defined as ICD-10 codes E78 as secondary
diagnoses). The age- and gender-specific prevalence
estimates are contrasted in Figure 7. There was a fair
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Figure 5 Comparison of age- and gender-specific prevalence estimates of diabetes mellitus based on complementary data sources.
Diabetes mellitus was defined as drug use or diagnosis of diabetes mellitus in Swiss health survey (SHS), as drug use or diagnosis of diabetes
mellitus or glucose measurement (serum glucose ≥11.1 mmol/L or HbA1c ≥6.5%) in primary care data (FIRE), and as ICD-10 codes E10-14 as
secondary diagnoses in hospital discharge statistics (MEDSTAT). Results based on less than 30 observations are marked by an asterisk. (Data
sources: Swiss Federal Statistical Office for Swiss Health Survey [SHS] and Hospital Discharge Statistics [MEDSTAT]; Swiss Family Medicine
International Classification of Primary Care Research using Electronic Medical Record project for primary care data [FIRE]).
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Figure 6 Comparison of age- and gender-specific prevalence estimates of hypertension based on complementary data sources.
Hypertension was defined as drug use alone in Swiss Health Survey (SHS), as drug use alone in primary care data (FIRE), and as ICD-10 codes I10-I15 or
I67.4 as secondary diagnoses in hospital discharge statistics (MEDSTAT). Results based on less than 30 observations are marked by an asterisk.
(Data sources: Swiss Federal Statistical Office for Swiss Health Survey [SHS] and Hospital Discharge Statistics [MEDSTAT]; Swiss Family Medicine
International Classification of Primary Care Research using Electronic Medical Record project for primary care data [FIRE]).
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agreement between SHS and FIRE, with SHS underesti-
mating slightly in the age class 75-84 years. However,
MEDSTAT underestimated the prevalence rate systematic-
ally by close to 50% for all age groups, although the age-
and gender-specific distribution remained similar. A sharp
decline in prevalence of dyslipidemia was observed for the
oldest age class (85-94 years) and for both genders in all
three data sources.
Obesity
The age- and gender-specific prevalence rates of obes-
ity based on SHS (defined as BMI ≥30 kg/m2 derived
from self-reported height and weight), FIRE (defined
as BMI ≥30 kg/m2 derived from measured height and
weight or diagnosis of obesity), and MEDSTAT (de-
fined as ICD-10 code E66 as secondary diagnoses) are
contrasted in Figure 8. Although there was generally a
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Figure 7 Comparison of age- and gender-specific prevalence estimates of dyslipidemia based on complementary data sources.
Dyslipidemia was defined as drug use alone in Swiss Health Survey (SHS), as drug use alone in primary care data (FIRE), and as ICD-10 code E78
as secondary diagnosis in hospital discharge statistics (MEDSTAT). Results based on less than 30 observations are marked by an asterisk. (Data
sources: Swiss Federal Statistical Office for Swiss Health Survey [SHS] and Hospital Discharge Statistics [MEDSTAT]; Swiss Family Medicine
International Classification of Primary Care Research using Electronic Medical Record project for primary care data [FIRE]).
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Figure 8 Comparison of age- and gender-specific prevalence estimates of obesity based on complementary data sources. Obesity was
defined as BMI ≥30 kg/m2 derived from self-reported height and weight in Swiss Health Survey (SHS), as BMI ≥30 kg/m2 derived from measured
height and weight or diagnosis of obesity in primary care data (FIRE), and as ICD-10 code s E66 as secondary diagnosis in hospital discharge
statistics (MEDSTAT). Results based on less than 30 observations are marked by an asterisk. (Data sources: Swiss Federal Statistical Office for Swiss
Health Survey [SHS] and Hospital Discharge Statistics [MEDSTAT]; Swiss Family Medicine International Classification of Primary Care Research using
Electronic Medical Record project for primary care data [FIRE]).
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slight underestimation in SHS and severe underestimation
in MEDSTAT, the age- and gender-specific prevalence dis-
tribution was similar for all data sources. A sharp decline
in the prevalence of obesity was observed for the oldest
age classes (75-84 and 85-94 years) and both genders in
all data sources.
Discussion
To date, only a few papers reported prevalence estimates
derived from different data sources, usually contrasting na-
tional or regional health surveys with pooled data from pri-
mary care. Examples are studies from Spain [8,9], the UK
[10], Germany [11], and Italy [12]. All these studies aimed
at scrutinizing the comparability of data from different
sources in order to endorse the validity of prevalence
estimates.
In our study, although the prevalence estimates varied
substantially, depending on the methodology used to
define a specific chronic medical condition (case defin-
ition) and on the nature of data source explored (health
survey, primary care, and hospital discharge), a high
degree of concordance could be achieved regarding age-
and gender-related patterns for four common cardiovas-
cular risk factors. Therefore, prevalence estimates of
chronic medical conditions based on primary care data
and hospital discharge statistics usually can be general-
ized to the population after a careful and appropriate
harmonization of the case definitions.
Comparison with other studies
In line with others [8-10,13], concordance between health
survey and primary care data was good for clearly defined
chronic conditions (diabetes and hypertension), and fair for
chronic conditions with a less clear cut-off (dyslipidemia
and obesity). While for diabetes comprehensive definitions
performed best, for hypertension and dyslipidemia building
the case definition on drug use alone was more effi-
cient. Hospital data performed well for clearly defined
diagnoses (diabetes, hypertension), but underreported
severely chronic conditions with a less clear cut-off
(dyslipidemia, obesity).
Our prevalence estimates are fairly in accordance with
the few Swiss studies, which explored the prevalence rates
of cardiovascular risk factors. However, generalizability of
these studies cannot be taken for granted, since they
were either limited to a single city [14-16] or based on
pharmacy claims with no access to clinical information
[17] and probably limited regarding international com-
parability [18].
Strengths and limitations
The main strength of our study is the inclusion of three
and not only two data sources, which provide comple-
mentary information and open possibilities for further
analyses of other chronic conditions. While there have
been efforts to compare health survey and primary care
data in several countries – to our knowledge the inclu-
sion of hospital discharge statistics is rather novel.
Limitations of our study are due to properties of the
different data sources. For instance, the SHS has a ra-
ther small number of participants and is restricted to
self-reports. Participation is voluntary and therefore
incomplete (66%), promoting a selection bias toward
health-aware individuals, potentially having less chronic
conditions but also favoring over reporting. FIRE on the
other side, has a limited number of participating practices
(81), which are not necessarily representative of the study
region. Furthermore, FIRE captures the actual prevalence
of chronic conditions among persons attending general
practices, and not necessarily the prevalence in the general
population, thus favoring over estimation due to selection
bias of sicker patients. FIRE is based on voluntary partici-
pation and might have incomplete data. Similarly, MED-
STAT is limited to inpatients, which might have more
chronic medical conditions than the general population.
These characteristics have to be taken into consideration
when drawing conclusions about the general population.
Nevertheless, SHS, FIRE and MEDSTAT represent cur-
rently the largest and most comprehensive health data
sources in Switzerland.
One could argue that comparisons between the data
sources are problematic due to different definitions of
the chronic conditions explored. However, our results
show that a careful harmonization of the definitions is
the key method. Since our study focused on the com-
plementation of different data sources, an important
question concerning definitions of chronic conditions
remained unanswered: How arbitrary are the defini-
tions of chronic health conditions based on cut-off-
values, for instance dyslipidemia? Both, the definition
based on lipid values and the definition based on drug
use are fallible, because the lipid cut-off values are
based on a variable expert opinion and the indication
for medication depends on the patients’ need for sec-
ondary prevention (while drug use for primary preven-
tion remains disputed). As a result, none of the definitions
is comprehensive and all are prone to over- or underesti-
mating bias. The identification of hypertension based on
drug use is even more complicated because antihyperten-
sive drugs can be used for heart disease or renal disease as
well. However, many patients with renal disease or heart
disease have hypertension. We calculated the prevalence
rates for hypertension including and excluding patients
who had renal disease or heart disease, and found min-
imal differences (not shown). Therefore, we provide
prevalence estimates for hypertension based on antihyper-
tensive drug use without excluding patients with heart
failure or renal disease.
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Conclusion
We conclude that complementary data from different data
sources might generate different prevalence estimates of
chronic medical conditions in the general population. How-
ever, common age and sex patterns indicate that a careful
harmonization of the definitions of chronic health conditions
will provide strikingly similar age-and gender-specific distri-
butions, even in data sources based on different settings and
assessment methods. This kind of cross-validation opens
vast potentials for analyses of prevalence estimates of other
chronic health conditions as well as multimorbidity in
specific subpopulations. Still, the development of generally
accepted condition-specific case definitions remains crucial.
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